OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables)
|
3 Months Ended |
Mar. 31, 2022 |
|---|
| Disclosure Text Block Supplement [Abstract] |
|
| Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block] |
The following table presents information related to stock options at March 31, 2022:
|
|
Options Outstanding
|
|
|
Options Exercisable
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
Exercisable
|
|
|
|
Exercise
|
|
|
Number of
|
|
|
Remaining Life
|
|
|
Number of
|
|
|
|
Price
|
|
|
Options
|
|
|
In Years
|
|
|
Options
|
|
|
|
$
|
Under 2.00 |
|
|
|
736,000 |
|
|
|
9.9 |
|
|
|
75,000 |
|
|
|
|
2.00-2.99 |
|
|
|
1,000,375 |
|
|
|
9.4 |
|
|
|
549,375 |
|
|
|
|
3.00-3.99 |
|
|
|
587,466 |
|
|
|
4.1 |
|
|
|
387,466 |
|
| |
|
4.00-4.99 |
|
|
|
1,547,916 |
|
|
|
6.2 |
|
|
|
1,136,573 |
|
|
|
|
5.00-5.99 |
|
|
|
156,132 |
|
|
|
6.9 |
|
|
|
124,046 |
|
|
|
|
6.00-6.99 |
|
|
|
461,542 |
|
|
|
5.0 |
|
|
|
389,515 |
|
|
|
|
7.00-7.99 |
|
|
|
186,720 |
|
|
|
6.6 |
|
|
|
176,721 |
|
|
|
|
Over 8.00 |
|
|
|
193,333 |
|
|
|
7.6 |
|
|
|
168,461 |
|
|
|
|
|
|
|
|
4,869,484 |
|
|
|
7.2 |
|
|
|
3,007,157 |
|
|
Options Outstanding
|
|
|
Options Exercisable
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
Exercisable
|
|
|
Exercise
|
|
|
Number of
|
|
|
Remaining Life
|
|
|
Number of
|
|
|
Price
|
|
|
Options
|
|
|
In Years
|
|
|
Options
|
|
|
$
|
5.00 |
|
|
|
125,000 |
|
|
|
6.9 |
|
|
|
91,664 |
|
|
| Share-Based Payment Arrangement, Option, Activity [Table Text Block] |
A summary of the stock option activity and related information for the Plan for the three months ended March 31, 2022 is as follows:
| |
|
|
|
|
|
|
|
|
|
Weighted-Average
|
|
|
|
|
|
| |
|
|
|
|
|
Weighted-Average
|
|
|
Remaining
|
|
|
Aggregate
|
|
| |
|
Shares
|
|
|
Exercise Price
|
|
|
Contractual Term
|
|
|
Intrinsic Value
|
|
|
Outstanding at December 31, 2021
|
|
|
4,568,484 |
|
|
$ |
4.57 |
|
|
|
6.9 |
|
|
$ |
- |
|
|
Grants
|
|
|
736,000 |
|
|
$ |
1.47 |
|
|
|
10.0 |
|
|
$ |
- |
|
|
Forfeited/expired
|
|
|
(435,000 |
)
|
|
$ |
5.36 |
|
|
|
|
|
|
|
|
|
|
Outstanding at March 31, 2022
|
|
|
4,869,484 |
|
|
$ |
4.03 |
|
|
|
7.2 |
|
|
$ |
- |
|
|
Exercisable at March 31, 2022
|
|
|
3,007,157 |
|
|
$ |
4.68 |
|
|
|
6.4 |
|
|
$ |
- |
|
|
| Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] |
The following assumptions were used in determining the fair value of options during the three months ended March 31, 2022:
|
Risk-free interest rate
|
|
|
1.17% - 2.43
|
%
|
|
Dividend yield
|
|
|
0 |
% |
|
Stock price volatility
|
|
|
83.83% to 92.93 |
% |
|
Expected life
|
|
6 to 10 years |
|
|
Weighted average grant date fair value
|
|
$
|
1.06 |
|
|
Risk-free interest rate
|
|
|
0.44% - 1.95
|
%
|
|
Dividend yield
|
|
|
0 |
% |
|
Stock price volatility
|
|
|
83.86 |
% |
|
Expected life
|
|
0.25 – 2 years |
|
|
| Schedule of Warrants or Rights, Shares Authorized, by Exercise Price Range [Table Text Block] |
The following table summarizes information with respect to outstanding warrants to purchase common stock of BioSig Technologies, Inc. at March 31, 2022:
|
|
Exercise
|
|
|
Number
|
|
Expiration
|
|
|
Price
|
|
|
Outstanding
|
|
Date
|
| |
$
|
1.40 |
|
|
|
2,613,130 |
|
September 2025 |
|
|
$
|
4.80 |
|
|
|
250,000 |
|
February 2025 to July 2026 |
|
|
$
|
6.16 |
|
|
|
568,910 |
|
November 2027 |
|
|
|
|
|
|
|
3,432,040 |
|
|
|
| Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] |
A summary of the warrant activity for the three months ended March 31, 2022 is as follows:
| |
|
|
|
|
|
|
|
|
|
Weighted-Average
|
|
|
|
|
|
| |
|
|
|
|
|
Weighted-Average
|
|
|
Remaining
|
|
|
Aggregate
|
|
| |
|
Shares
|
|
|
Exercise Price
|
|
|
Contractual Term
|
|
|
Intrinsic Value
|
|
|
Outstanding at December 31, 2021
|
|
|
818,910 |
|
|
$ |
5.74 |
|
|
|
5.3 |
|
|
$ |
- |
|
|
Issued
|
|
|
2,613,130 |
|
|
$ |
1.40 |
|
|
|
3.5 |
|
|
|
- |
|
|
Outstanding at March 31, 2022
|
|
|
3,432,040 |
|
|
$ |
2.44 |
|
|
|
3.8 |
|
|
$ |
- |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vested and expected to vest at March 31, 2022
|
|
|
3,432,040 |
|
|
$ |
2.44 |
|
|
|
3.8 |
|
|
$ |
- |
|
|
Exercisable at March 31, 2022
|
|
|
818,910 |
|
|
$ |
5.74 |
|
|
|
5.0 |
|
|
$ |
- |
|
|
| Nonvested Restricted Stock Shares Activity [Table Text Block] |
The following table summarizes the restricted stock activity for the three months ended March 31, 2022:
|
Restricted shares issued as of December 31, 2021
|
|
|
141,250 |
|
|
Granted
|
|
|
37,500 |
|
|
Vested and issued
|
|
|
(66,249 |
)
|
|
Forfeited
|
|
|
(30,001 |
)
|
|
Vested restricted shares as of March 31, 2022
|
|
|
- |
|
|
Unvested restricted shares as of March 31, 2022
|
|
|
82,500 |
|
|
Restricted shares outstanding at December 31, 2021:
|
|
|
1,318,679 |
|
|
Forfeited
|
|
|
(80,000 |
)
|
|
Total restricted shares outstanding at March 31, 2022:
|
|
|
1,238,679 |
|
| |
|
|
|
|
|
Comprised of:
|
|
|
|
|
|
Vested restricted shares as of March 31, 2022
|
|
|
678,679 |
|
|
Unvested restricted shares as of March 31, 2022
|
|
|
560,000 |
|
|
Total
|
|
|
1,238,679 |
|
|
| Schedule of Warrants or Rights, Shares Authorized, Exercise Price Range [Table Text Block] |
The following table presents information related to warrants (ViralClear) at March 31, 2022:
|
|
Exercise
|
|
|
Number
|
|
Expiration
|
|
|
Price
|
|
|
Outstanding
|
|
Date
|
|
|
$
|
5.00 |
|
|
|
473,772 |
|
November 2027 |
|
|
|
10.00 |
|
|
|
6,575 |
|
May 2025 |
|
|
|
|
|
|
|
480,347 |
|
|
|